Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trials (Q38005018)

26 August 2017

Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trials (English)

1 reference

26 August 2017

acute coronary syndrome

1 reference

Sanjum S Sethi

1

1 reference

26 August 2017

Elias G Akl

series ordinal

2

1 reference

26 August 2017

Michael E Farkouh

series ordinal

3

1 reference

26 August 2017

1 June 2012

1 reference

26 August 2017

Current diabetes report

1 reference

26 August 2017

12

1 reference

26 August 2017

3

1 reference

26 August 2017

294-304

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-012-0272-9

26 August 2017

0 references

cites work

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Usefulness of diabetes mellitus to predict long-term outcomes in patients with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

New aspects in the pathogenesis of diabetic atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Changing concepts of atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Glucose normalization and outcomes in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Acute coronary syndromes and diabetes mellitus: a winning ticket for prasugrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Diabetes and antiplatelet therapy in acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Suboptimal inhibition of platelet cyclooxygenase-1 by aspirin in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Bivalirudin for patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Bivalirudin during primary PCI in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Diabetes and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Implications of Diabetes in Patients With Acute Coronary Syndromes The Global Registry of Acute Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0272-9

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

21 January 2018

1 reference

12 December 2020

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY

1 reference

12 December 2020

Primary Percutaneous Coronary Intervention Compared With Fibrinolysis for Myocardial Infarction in Diabetes Mellitus

1 reference

12 December 2020

Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute M

1 reference

12 December 2020

Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials

1 reference

12 December 2020

Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes

1 reference

12 December 2020

Diabetes and mortality following acute coronary syndromes

1 reference

12 December 2020

Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation

1 reference

12 December 2020

Increased Platelet Aggregation in Early Diabetus Mellitus

1 reference

12 December 2020

Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial

1 reference

12 December 2020

Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

12 December 2020

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance

1 reference

12 December 2020

Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes

1 reference

12 December 2020

Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome population

1 reference

12 December 2020

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

12 December 2020

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry

1 reference

12 December 2020

Role of endothelial dysfunction in atherosclerosis

1 reference

12 December 2020

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Aspirin, heparin, or both to treat acute unstable angina

1 reference

12 December 2020

Hemostasis variables in type I diabetic patients without demonstrable vascular complications

1 reference

12 December 2020

Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus

1 reference

12 December 2020

10.1007/S11892-012-0272-9

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference